nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—MAOA—Zonisamide—epilepsy syndrome	0.195	1	CbGbCtD
Naratriptan—HTR1D—meninx—epilepsy syndrome	0.0275	0.197	CbGeAlD
Naratriptan—MAOA—locus ceruleus—epilepsy syndrome	0.0101	0.0723	CbGeAlD
Naratriptan—HTR1F—ganglion—epilepsy syndrome	0.0099	0.0707	CbGeAlD
Naratriptan—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00651	0.0465	CbGeAlD
Naratriptan—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00631	0.045	CbGeAlD
Naratriptan—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00526	0.0375	CbGeAlD
Naratriptan—HTR1F—forebrain—epilepsy syndrome	0.00415	0.0297	CbGeAlD
Naratriptan—HTR1B—ganglion—epilepsy syndrome	0.00405	0.029	CbGeAlD
Naratriptan—HTR1D—ganglion—epilepsy syndrome	0.00393	0.028	CbGeAlD
Naratriptan—HTR1F—telencephalon—epilepsy syndrome	0.00382	0.0273	CbGeAlD
Naratriptan—HTR1A—ganglion—epilepsy syndrome	0.00327	0.0234	CbGeAlD
Naratriptan—MAOA—ganglion—epilepsy syndrome	0.00299	0.0214	CbGeAlD
Naratriptan—HTR1A—hindbrain—epilepsy syndrome	0.00248	0.0177	CbGeAlD
Naratriptan—HTR1F—head—epilepsy syndrome	0.00238	0.017	CbGeAlD
Naratriptan—MAOA—hindbrain—epilepsy syndrome	0.00227	0.0162	CbGeAlD
Naratriptan—HTR1F—nervous system—epilepsy syndrome	0.00225	0.0161	CbGeAlD
Naratriptan—HTR1F—central nervous system—epilepsy syndrome	0.00217	0.0155	CbGeAlD
Naratriptan—Sumatriptan—SLCO1A2—epilepsy syndrome	0.00212	0.308	CrCbGaD
Naratriptan—HTR1B—brainstem—epilepsy syndrome	0.00176	0.0126	CbGeAlD
Naratriptan—HTR1F—brain—epilepsy syndrome	0.00172	0.0123	CbGeAlD
Naratriptan—HTR1D—brainstem—epilepsy syndrome	0.00171	0.0122	CbGeAlD
Naratriptan—HTR1B—forebrain—epilepsy syndrome	0.0017	0.0122	CbGeAlD
Naratriptan—HTR1D—forebrain—epilepsy syndrome	0.00165	0.0118	CbGeAlD
Naratriptan—HTR1B—telencephalon—epilepsy syndrome	0.00156	0.0112	CbGeAlD
Naratriptan—HTR1D—telencephalon—epilepsy syndrome	0.00151	0.0108	CbGeAlD
Naratriptan—HTR1A—brainstem—epilepsy syndrome	0.00142	0.0102	CbGeAlD
Naratriptan—HTR1A—forebrain—epilepsy syndrome	0.00137	0.00981	CbGeAlD
Naratriptan—MAOA—brainstem—epilepsy syndrome	0.0013	0.00928	CbGeAlD
Naratriptan—HTR1A—telencephalon—epilepsy syndrome	0.00126	0.00902	CbGeAlD
Naratriptan—MAOA—forebrain—epilepsy syndrome	0.00125	0.00896	CbGeAlD
Naratriptan—MAOA—telencephalon—epilepsy syndrome	0.00115	0.00824	CbGeAlD
Naratriptan—HTR1B—midbrain—epilepsy syndrome	0.00112	0.00802	CbGeAlD
Naratriptan—HTR1B—spinal cord—epilepsy syndrome	0.0011	0.00783	CbGeAlD
Naratriptan—HTR1D—midbrain—epilepsy syndrome	0.00109	0.00777	CbGeAlD
Naratriptan—HTR1B—head—epilepsy syndrome	0.000974	0.00696	CbGeAlD
Naratriptan—HTR1D—head—epilepsy syndrome	0.000943	0.00674	CbGeAlD
Naratriptan—HTR1B—nervous system—epilepsy syndrome	0.000923	0.0066	CbGeAlD
Naratriptan—Eletriptan—HTR7—epilepsy syndrome	0.000918	0.134	CrCbGaD
Naratriptan—HTR1A—midbrain—epilepsy syndrome	0.000906	0.00647	CbGeAlD
Naratriptan—MAOA—medulla oblongata—epilepsy syndrome	0.000906	0.00647	CbGeAlD
Naratriptan—Sumatriptan—ABCG2—epilepsy syndrome	0.000895	0.13	CrCbGaD
Naratriptan—HTR1D—nervous system—epilepsy syndrome	0.000894	0.00639	CbGeAlD
Naratriptan—HTR1B—central nervous system—epilepsy syndrome	0.000889	0.00635	CbGeAlD
Naratriptan—HTR1A—spinal cord—epilepsy syndrome	0.000884	0.00632	CbGeAlD
Naratriptan—HTR1D—central nervous system—epilepsy syndrome	0.000861	0.00615	CbGeAlD
Naratriptan—MAOA—midbrain—epilepsy syndrome	0.000828	0.00592	CbGeAlD
Naratriptan—MAOA—spinal cord—epilepsy syndrome	0.000808	0.00577	CbGeAlD
Naratriptan—HTR1A—head—epilepsy syndrome	0.000786	0.00561	CbGeAlD
Naratriptan—HTR1A—nervous system—epilepsy syndrome	0.000745	0.00532	CbGeAlD
Naratriptan—Almotriptan—CYP2C19—epilepsy syndrome	0.000731	0.106	CrCbGaD
Naratriptan—MAOA—head—epilepsy syndrome	0.000718	0.00513	CbGeAlD
Naratriptan—HTR1A—central nervous system—epilepsy syndrome	0.000717	0.00512	CbGeAlD
Naratriptan—HTR1B—brain—epilepsy syndrome	0.000706	0.00504	CbGeAlD
Naratriptan—HTR1A—cerebellum—epilepsy syndrome	0.000701	0.00501	CbGeAlD
Naratriptan—HTR1D—brain—epilepsy syndrome	0.000683	0.00488	CbGeAlD
Naratriptan—MAOA—nervous system—epilepsy syndrome	0.000681	0.00486	CbGeAlD
Naratriptan—MAOA—central nervous system—epilepsy syndrome	0.000655	0.00468	CbGeAlD
Naratriptan—MAOA—cerebellum—epilepsy syndrome	0.000641	0.00458	CbGeAlD
Naratriptan—HTR1A—brain—epilepsy syndrome	0.00057	0.00407	CbGeAlD
Naratriptan—Eletriptan—CYP2C19—epilepsy syndrome	0.000569	0.0829	CrCbGaD
Naratriptan—Almotriptan—CYP2D6—epilepsy syndrome	0.000542	0.0789	CrCbGaD
Naratriptan—MAOA—brain—epilepsy syndrome	0.00052	0.00372	CbGeAlD
Naratriptan—Eletriptan—CYP2D6—epilepsy syndrome	0.000422	0.0615	CrCbGaD
Naratriptan—Sumatriptan—ABCB1—epilepsy syndrome	0.000372	0.0542	CrCbGaD
Naratriptan—Eletriptan—ABCB1—epilepsy syndrome	0.000301	0.0439	CrCbGaD
Naratriptan—Rash—Fosphenytoin—epilepsy syndrome	0.000101	0.000229	CcSEcCtD
Naratriptan—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000101	0.000229	CcSEcCtD
Naratriptan—Haemoglobin—Topiramate—epilepsy syndrome	0.000101	0.000229	CcSEcCtD
Naratriptan—Asthenia—Clonazepam—epilepsy syndrome	0.000101	0.000229	CcSEcCtD
Naratriptan—Headache—Fosphenytoin—epilepsy syndrome	0.0001	0.000228	CcSEcCtD
Naratriptan—Haemorrhage—Topiramate—epilepsy syndrome	0.0001	0.000228	CcSEcCtD
Naratriptan—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.0001	0.000228	CcSEcCtD
Naratriptan—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.0001	0.000227	CcSEcCtD
Naratriptan—Palpitations—Pregabalin—epilepsy syndrome	9.99e-05	0.000227	CcSEcCtD
Naratriptan—Asthenia—Phenytoin—epilepsy syndrome	9.99e-05	0.000227	CcSEcCtD
Naratriptan—Nausea—Midazolam—epilepsy syndrome	9.97e-05	0.000227	CcSEcCtD
Naratriptan—Hypoaesthesia—Topiramate—epilepsy syndrome	9.97e-05	0.000227	CcSEcCtD
Naratriptan—Hallucination—Topiramate—epilepsy syndrome	9.97e-05	0.000227	CcSEcCtD
Naratriptan—Muscle spasms—Gabapentin—epilepsy syndrome	9.97e-05	0.000227	CcSEcCtD
Naratriptan—Diarrhoea—Zonisamide—epilepsy syndrome	9.95e-05	0.000226	CcSEcCtD
Naratriptan—Loss of consciousness—Pregabalin—epilepsy syndrome	9.94e-05	0.000226	CcSEcCtD
Naratriptan—Asthenia—Oxcarbazepine—epilepsy syndrome	9.94e-05	0.000226	CcSEcCtD
Naratriptan—Pruritus—Clonazepam—epilepsy syndrome	9.92e-05	0.000225	CcSEcCtD
Naratriptan—Vomiting—Vigabatrin—epilepsy syndrome	9.92e-05	0.000225	CcSEcCtD
Naratriptan—Skin disorder—Valproic Acid—epilepsy syndrome	9.92e-05	0.000225	CcSEcCtD
Naratriptan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.87e-05	0.000224	CcSEcCtD
Naratriptan—Cough—Pregabalin—epilepsy syndrome	9.87e-05	0.000224	CcSEcCtD
Naratriptan—Pruritus—Phenytoin—epilepsy syndrome	9.85e-05	0.000224	CcSEcCtD
Naratriptan—Nausea—Levetiracetam—epilepsy syndrome	9.85e-05	0.000224	CcSEcCtD
Naratriptan—Rash—Vigabatrin—epilepsy syndrome	9.83e-05	0.000224	CcSEcCtD
Naratriptan—Dizziness—Felbamate—epilepsy syndrome	9.83e-05	0.000223	CcSEcCtD
Naratriptan—Dermatitis—Vigabatrin—epilepsy syndrome	9.82e-05	0.000223	CcSEcCtD
Naratriptan—Pruritus—Oxcarbazepine—epilepsy syndrome	9.8e-05	0.000223	CcSEcCtD
Naratriptan—Convulsion—Pregabalin—epilepsy syndrome	9.8e-05	0.000223	CcSEcCtD
Naratriptan—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.79e-05	0.000223	CcSEcCtD
Naratriptan—Vision blurred—Gabapentin—epilepsy syndrome	9.77e-05	0.000222	CcSEcCtD
Naratriptan—Headache—Vigabatrin—epilepsy syndrome	9.77e-05	0.000222	CcSEcCtD
Naratriptan—Vomiting—Diazepam—epilepsy syndrome	9.76e-05	0.000222	CcSEcCtD
Naratriptan—Tremor—Gabapentin—epilepsy syndrome	9.72e-05	0.000221	CcSEcCtD
Naratriptan—Rash—Diazepam—epilepsy syndrome	9.68e-05	0.00022	CcSEcCtD
Naratriptan—Dermatitis—Diazepam—epilepsy syndrome	9.67e-05	0.00022	CcSEcCtD
Naratriptan—Myalgia—Pregabalin—epilepsy syndrome	9.63e-05	0.000219	CcSEcCtD
Naratriptan—Arthralgia—Pregabalin—epilepsy syndrome	9.63e-05	0.000219	CcSEcCtD
Naratriptan—Ill-defined disorder—Gabapentin—epilepsy syndrome	9.62e-05	0.000219	CcSEcCtD
Naratriptan—Dizziness—Zonisamide—epilepsy syndrome	9.62e-05	0.000219	CcSEcCtD
Naratriptan—Headache—Diazepam—epilepsy syndrome	9.62e-05	0.000219	CcSEcCtD
Naratriptan—Anxiety—Pregabalin—epilepsy syndrome	9.59e-05	0.000218	CcSEcCtD
Naratriptan—Diarrhoea—Clonazepam—epilepsy syndrome	9.59e-05	0.000218	CcSEcCtD
Naratriptan—Anaemia—Gabapentin—epilepsy syndrome	9.58e-05	0.000218	CcSEcCtD
Naratriptan—Hypotension—Valproic Acid—epilepsy syndrome	9.54e-05	0.000217	CcSEcCtD
Naratriptan—Asthenia—Carbamazepine—epilepsy syndrome	9.54e-05	0.000217	CcSEcCtD
Naratriptan—Agitation—Gabapentin—epilepsy syndrome	9.53e-05	0.000217	CcSEcCtD
Naratriptan—Diarrhoea—Phenytoin—epilepsy syndrome	9.53e-05	0.000217	CcSEcCtD
Naratriptan—Discomfort—Pregabalin—epilepsy syndrome	9.51e-05	0.000216	CcSEcCtD
Naratriptan—Nausea—Fosphenytoin—epilepsy syndrome	9.5e-05	0.000216	CcSEcCtD
Naratriptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.48e-05	0.000215	CcSEcCtD
Naratriptan—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.47e-05	0.000215	CcSEcCtD
Naratriptan—Vomiting—Felbamate—epilepsy syndrome	9.45e-05	0.000215	CcSEcCtD
Naratriptan—Dry mouth—Pregabalin—epilepsy syndrome	9.42e-05	0.000214	CcSEcCtD
Naratriptan—Pruritus—Carbamazepine—epilepsy syndrome	9.4e-05	0.000214	CcSEcCtD
Naratriptan—Rash—Felbamate—epilepsy syndrome	9.37e-05	0.000213	CcSEcCtD
Naratriptan—Dermatitis—Felbamate—epilepsy syndrome	9.36e-05	0.000213	CcSEcCtD
Naratriptan—Malaise—Gabapentin—epilepsy syndrome	9.35e-05	0.000213	CcSEcCtD
Naratriptan—Tinnitus—Topiramate—epilepsy syndrome	9.34e-05	0.000212	CcSEcCtD
Naratriptan—Vertigo—Gabapentin—epilepsy syndrome	9.32e-05	0.000212	CcSEcCtD
Naratriptan—Headache—Felbamate—epilepsy syndrome	9.31e-05	0.000212	CcSEcCtD
Naratriptan—Confusional state—Pregabalin—epilepsy syndrome	9.31e-05	0.000212	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.3e-05	0.000211	CcSEcCtD
Naratriptan—Cardiac disorder—Topiramate—epilepsy syndrome	9.3e-05	0.000211	CcSEcCtD
Naratriptan—Syncope—Gabapentin—epilepsy syndrome	9.3e-05	0.000211	CcSEcCtD
Naratriptan—Dizziness—Clonazepam—epilepsy syndrome	9.27e-05	0.000211	CcSEcCtD
Naratriptan—Nausea—Vigabatrin—epilepsy syndrome	9.26e-05	0.000211	CcSEcCtD
Naratriptan—Vomiting—Zonisamide—epilepsy syndrome	9.25e-05	0.00021	CcSEcCtD
Naratriptan—Oedema—Pregabalin—epilepsy syndrome	9.23e-05	0.00021	CcSEcCtD
Naratriptan—Anaphylactic shock—Pregabalin—epilepsy syndrome	9.23e-05	0.00021	CcSEcCtD
Naratriptan—Asthenia—Lamotrigine—epilepsy syndrome	9.22e-05	0.000209	CcSEcCtD
Naratriptan—Dizziness—Phenytoin—epilepsy syndrome	9.21e-05	0.000209	CcSEcCtD
Naratriptan—Rash—Zonisamide—epilepsy syndrome	9.17e-05	0.000208	CcSEcCtD
Naratriptan—Infection—Pregabalin—epilepsy syndrome	9.17e-05	0.000208	CcSEcCtD
Naratriptan—Paraesthesia—Valproic Acid—epilepsy syndrome	9.17e-05	0.000208	CcSEcCtD
Naratriptan—Palpitations—Gabapentin—epilepsy syndrome	9.16e-05	0.000208	CcSEcCtD
Naratriptan—Dermatitis—Zonisamide—epilepsy syndrome	9.16e-05	0.000208	CcSEcCtD
Naratriptan—Dizziness—Oxcarbazepine—epilepsy syndrome	9.16e-05	0.000208	CcSEcCtD
Naratriptan—Nausea—Diazepam—epilepsy syndrome	9.12e-05	0.000207	CcSEcCtD
Naratriptan—Loss of consciousness—Gabapentin—epilepsy syndrome	9.11e-05	0.000207	CcSEcCtD
Naratriptan—Headache—Zonisamide—epilepsy syndrome	9.11e-05	0.000207	CcSEcCtD
Naratriptan—Dyspnoea—Valproic Acid—epilepsy syndrome	9.1e-05	0.000207	CcSEcCtD
Naratriptan—Diarrhoea—Carbamazepine—epilepsy syndrome	9.1e-05	0.000207	CcSEcCtD
Naratriptan—Angiopathy—Topiramate—epilepsy syndrome	9.09e-05	0.000207	CcSEcCtD
Naratriptan—Pruritus—Lamotrigine—epilepsy syndrome	9.09e-05	0.000207	CcSEcCtD
Naratriptan—Shock—Pregabalin—epilepsy syndrome	9.08e-05	0.000206	CcSEcCtD
Naratriptan—Somnolence—Valproic Acid—epilepsy syndrome	9.08e-05	0.000206	CcSEcCtD
Naratriptan—Immune system disorder—Topiramate—epilepsy syndrome	9.05e-05	0.000206	CcSEcCtD
Naratriptan—Nervous system disorder—Pregabalin—epilepsy syndrome	9.05e-05	0.000206	CcSEcCtD
Naratriptan—Cough—Gabapentin—epilepsy syndrome	9.05e-05	0.000206	CcSEcCtD
Naratriptan—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.04e-05	0.000205	CcSEcCtD
Naratriptan—Chills—Topiramate—epilepsy syndrome	8.99e-05	0.000204	CcSEcCtD
Naratriptan—Convulsion—Gabapentin—epilepsy syndrome	8.98e-05	0.000204	CcSEcCtD
Naratriptan—Skin disorder—Pregabalin—epilepsy syndrome	8.96e-05	0.000204	CcSEcCtD
Naratriptan—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.92e-05	0.000203	CcSEcCtD
Naratriptan—Vomiting—Clonazepam—epilepsy syndrome	8.91e-05	0.000203	CcSEcCtD
Naratriptan—Alopecia—Topiramate—epilepsy syndrome	8.86e-05	0.000201	CcSEcCtD
Naratriptan—Vomiting—Phenytoin—epilepsy syndrome	8.85e-05	0.000201	CcSEcCtD
Naratriptan—Rash—Clonazepam—epilepsy syndrome	8.84e-05	0.000201	CcSEcCtD
Naratriptan—Dermatitis—Clonazepam—epilepsy syndrome	8.83e-05	0.000201	CcSEcCtD
Naratriptan—Myalgia—Gabapentin—epilepsy syndrome	8.83e-05	0.000201	CcSEcCtD
Naratriptan—Arthralgia—Gabapentin—epilepsy syndrome	8.83e-05	0.000201	CcSEcCtD
Naratriptan—Nausea—Felbamate—epilepsy syndrome	8.83e-05	0.000201	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.81e-05	0.0002	CcSEcCtD
Naratriptan—Vomiting—Oxcarbazepine—epilepsy syndrome	8.81e-05	0.0002	CcSEcCtD
Naratriptan—Fatigue—Valproic Acid—epilepsy syndrome	8.8e-05	0.0002	CcSEcCtD
Naratriptan—Anxiety—Gabapentin—epilepsy syndrome	8.8e-05	0.0002	CcSEcCtD
Naratriptan—Dizziness—Carbamazepine—epilepsy syndrome	8.79e-05	0.0002	CcSEcCtD
Naratriptan—Diarrhoea—Lamotrigine—epilepsy syndrome	8.79e-05	0.0002	CcSEcCtD
Naratriptan—Headache—Clonazepam—epilepsy syndrome	8.78e-05	0.0002	CcSEcCtD
Naratriptan—Rash—Phenytoin—epilepsy syndrome	8.78e-05	0.0002	CcSEcCtD
Naratriptan—Dermatitis—Phenytoin—epilepsy syndrome	8.77e-05	0.000199	CcSEcCtD
Naratriptan—Rash—Oxcarbazepine—epilepsy syndrome	8.73e-05	0.000199	CcSEcCtD
Naratriptan—Pain—Valproic Acid—epilepsy syndrome	8.73e-05	0.000198	CcSEcCtD
Naratriptan—Constipation—Valproic Acid—epilepsy syndrome	8.73e-05	0.000198	CcSEcCtD
Naratriptan—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.73e-05	0.000198	CcSEcCtD
Naratriptan—Headache—Phenytoin—epilepsy syndrome	8.72e-05	0.000198	CcSEcCtD
Naratriptan—Erythema—Topiramate—epilepsy syndrome	8.72e-05	0.000198	CcSEcCtD
Naratriptan—Discomfort—Gabapentin—epilepsy syndrome	8.72e-05	0.000198	CcSEcCtD
Naratriptan—Headache—Oxcarbazepine—epilepsy syndrome	8.68e-05	0.000197	CcSEcCtD
Naratriptan—Nausea—Zonisamide—epilepsy syndrome	8.64e-05	0.000196	CcSEcCtD
Naratriptan—Dry mouth—Gabapentin—epilepsy syndrome	8.63e-05	0.000196	CcSEcCtD
Naratriptan—Hypotension—Pregabalin—epilepsy syndrome	8.62e-05	0.000196	CcSEcCtD
Naratriptan—Confusional state—Gabapentin—epilepsy syndrome	8.53e-05	0.000194	CcSEcCtD
Naratriptan—Dizziness—Lamotrigine—epilepsy syndrome	8.5e-05	0.000193	CcSEcCtD
Naratriptan—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.46e-05	0.000192	CcSEcCtD
Naratriptan—Oedema—Gabapentin—epilepsy syndrome	8.46e-05	0.000192	CcSEcCtD
Naratriptan—Vomiting—Carbamazepine—epilepsy syndrome	8.45e-05	0.000192	CcSEcCtD
Naratriptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.41e-05	0.000191	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.41e-05	0.000191	CcSEcCtD
Naratriptan—Infection—Gabapentin—epilepsy syndrome	8.41e-05	0.000191	CcSEcCtD
Naratriptan—Muscle spasms—Topiramate—epilepsy syndrome	8.39e-05	0.000191	CcSEcCtD
Naratriptan—Rash—Carbamazepine—epilepsy syndrome	8.38e-05	0.00019	CcSEcCtD
Naratriptan—Dermatitis—Carbamazepine—epilepsy syndrome	8.37e-05	0.00019	CcSEcCtD
Naratriptan—Nausea—Clonazepam—epilepsy syndrome	8.33e-05	0.000189	CcSEcCtD
Naratriptan—Headache—Carbamazepine—epilepsy syndrome	8.33e-05	0.000189	CcSEcCtD
Naratriptan—Shock—Gabapentin—epilepsy syndrome	8.33e-05	0.000189	CcSEcCtD
Naratriptan—Nervous system disorder—Gabapentin—epilepsy syndrome	8.3e-05	0.000189	CcSEcCtD
Naratriptan—Paraesthesia—Pregabalin—epilepsy syndrome	8.29e-05	0.000188	CcSEcCtD
Naratriptan—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.29e-05	0.000188	CcSEcCtD
Naratriptan—Nausea—Phenytoin—epilepsy syndrome	8.27e-05	0.000188	CcSEcCtD
Naratriptan—Dyspnoea—Pregabalin—epilepsy syndrome	8.23e-05	0.000187	CcSEcCtD
Naratriptan—Nausea—Oxcarbazepine—epilepsy syndrome	8.23e-05	0.000187	CcSEcCtD
Naratriptan—Vision blurred—Topiramate—epilepsy syndrome	8.22e-05	0.000187	CcSEcCtD
Naratriptan—Skin disorder—Gabapentin—epilepsy syndrome	8.22e-05	0.000187	CcSEcCtD
Naratriptan—Somnolence—Pregabalin—epilepsy syndrome	8.2e-05	0.000186	CcSEcCtD
Naratriptan—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.18e-05	0.000186	CcSEcCtD
Naratriptan—Tremor—Topiramate—epilepsy syndrome	8.17e-05	0.000186	CcSEcCtD
Naratriptan—Vomiting—Lamotrigine—epilepsy syndrome	8.17e-05	0.000186	CcSEcCtD
Naratriptan—Urticaria—Valproic Acid—epilepsy syndrome	8.11e-05	0.000184	CcSEcCtD
Naratriptan—Rash—Lamotrigine—epilepsy syndrome	8.1e-05	0.000184	CcSEcCtD
Naratriptan—Ill-defined disorder—Topiramate—epilepsy syndrome	8.09e-05	0.000184	CcSEcCtD
Naratriptan—Dermatitis—Lamotrigine—epilepsy syndrome	8.09e-05	0.000184	CcSEcCtD
Naratriptan—Body temperature increased—Valproic Acid—epilepsy syndrome	8.07e-05	0.000183	CcSEcCtD
Naratriptan—Anaemia—Topiramate—epilepsy syndrome	8.06e-05	0.000183	CcSEcCtD
Naratriptan—Headache—Lamotrigine—epilepsy syndrome	8.05e-05	0.000183	CcSEcCtD
Naratriptan—Agitation—Topiramate—epilepsy syndrome	8.02e-05	0.000182	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.97e-05	0.000181	CcSEcCtD
Naratriptan—Fatigue—Pregabalin—epilepsy syndrome	7.96e-05	0.000181	CcSEcCtD
Naratriptan—Hypotension—Gabapentin—epilepsy syndrome	7.91e-05	0.00018	CcSEcCtD
Naratriptan—Nausea—Carbamazepine—epilepsy syndrome	7.9e-05	0.000179	CcSEcCtD
Naratriptan—Pain—Pregabalin—epilepsy syndrome	7.89e-05	0.000179	CcSEcCtD
Naratriptan—Constipation—Pregabalin—epilepsy syndrome	7.89e-05	0.000179	CcSEcCtD
Naratriptan—Malaise—Topiramate—epilepsy syndrome	7.87e-05	0.000179	CcSEcCtD
Naratriptan—Vertigo—Topiramate—epilepsy syndrome	7.84e-05	0.000178	CcSEcCtD
Naratriptan—Syncope—Topiramate—epilepsy syndrome	7.82e-05	0.000178	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.71e-05	0.000175	CcSEcCtD
Naratriptan—Palpitations—Topiramate—epilepsy syndrome	7.71e-05	0.000175	CcSEcCtD
Naratriptan—Loss of consciousness—Topiramate—epilepsy syndrome	7.67e-05	0.000174	CcSEcCtD
Naratriptan—Nausea—Lamotrigine—epilepsy syndrome	7.63e-05	0.000173	CcSEcCtD
Naratriptan—Cough—Topiramate—epilepsy syndrome	7.61e-05	0.000173	CcSEcCtD
Naratriptan—Feeling abnormal—Pregabalin—epilepsy syndrome	7.61e-05	0.000173	CcSEcCtD
Naratriptan—Paraesthesia—Gabapentin—epilepsy syndrome	7.6e-05	0.000173	CcSEcCtD
Naratriptan—Convulsion—Topiramate—epilepsy syndrome	7.56e-05	0.000172	CcSEcCtD
Naratriptan—Dyspnoea—Gabapentin—epilepsy syndrome	7.54e-05	0.000171	CcSEcCtD
Naratriptan—Somnolence—Gabapentin—epilepsy syndrome	7.52e-05	0.000171	CcSEcCtD
Naratriptan—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.52e-05	0.000171	CcSEcCtD
Naratriptan—Myalgia—Topiramate—epilepsy syndrome	7.43e-05	0.000169	CcSEcCtD
Naratriptan—Arthralgia—Topiramate—epilepsy syndrome	7.43e-05	0.000169	CcSEcCtD
Naratriptan—Anxiety—Topiramate—epilepsy syndrome	7.4e-05	0.000168	CcSEcCtD
Naratriptan—Discomfort—Topiramate—epilepsy syndrome	7.34e-05	0.000167	CcSEcCtD
Naratriptan—Urticaria—Pregabalin—epilepsy syndrome	7.33e-05	0.000167	CcSEcCtD
Naratriptan—Asthenia—Valproic Acid—epilepsy syndrome	7.32e-05	0.000166	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.31e-05	0.000166	CcSEcCtD
Naratriptan—Fatigue—Gabapentin—epilepsy syndrome	7.3e-05	0.000166	CcSEcCtD
Naratriptan—Body temperature increased—Pregabalin—epilepsy syndrome	7.3e-05	0.000166	CcSEcCtD
Naratriptan—Dry mouth—Topiramate—epilepsy syndrome	7.26e-05	0.000165	CcSEcCtD
Naratriptan—Pain—Gabapentin—epilepsy syndrome	7.24e-05	0.000164	CcSEcCtD
Naratriptan—Constipation—Gabapentin—epilepsy syndrome	7.24e-05	0.000164	CcSEcCtD
Naratriptan—Pruritus—Valproic Acid—epilepsy syndrome	7.22e-05	0.000164	CcSEcCtD
Naratriptan—Confusional state—Topiramate—epilepsy syndrome	7.18e-05	0.000163	CcSEcCtD
Naratriptan—Oedema—Topiramate—epilepsy syndrome	7.12e-05	0.000162	CcSEcCtD
Naratriptan—Infection—Topiramate—epilepsy syndrome	7.07e-05	0.000161	CcSEcCtD
Naratriptan—Shock—Topiramate—epilepsy syndrome	7e-05	0.000159	CcSEcCtD
Naratriptan—Diarrhoea—Valproic Acid—epilepsy syndrome	6.98e-05	0.000159	CcSEcCtD
Naratriptan—Nervous system disorder—Topiramate—epilepsy syndrome	6.98e-05	0.000159	CcSEcCtD
Naratriptan—Feeling abnormal—Gabapentin—epilepsy syndrome	6.97e-05	0.000159	CcSEcCtD
Naratriptan—Thrombocytopenia—Topiramate—epilepsy syndrome	6.97e-05	0.000158	CcSEcCtD
Naratriptan—Skin disorder—Topiramate—epilepsy syndrome	6.92e-05	0.000157	CcSEcCtD
Naratriptan—Hyperhidrosis—Topiramate—epilepsy syndrome	6.88e-05	0.000156	CcSEcCtD
Naratriptan—Hypersensitivity—Pregabalin—epilepsy syndrome	6.8e-05	0.000155	CcSEcCtD
Naratriptan—Dizziness—Valproic Acid—epilepsy syndrome	6.75e-05	0.000153	CcSEcCtD
Naratriptan—Urticaria—Gabapentin—epilepsy syndrome	6.72e-05	0.000153	CcSEcCtD
Naratriptan—Body temperature increased—Gabapentin—epilepsy syndrome	6.69e-05	0.000152	CcSEcCtD
Naratriptan—Hypotension—Topiramate—epilepsy syndrome	6.65e-05	0.000151	CcSEcCtD
Naratriptan—Asthenia—Pregabalin—epilepsy syndrome	6.62e-05	0.00015	CcSEcCtD
Naratriptan—Pruritus—Pregabalin—epilepsy syndrome	6.53e-05	0.000148	CcSEcCtD
Naratriptan—Vomiting—Valproic Acid—epilepsy syndrome	6.49e-05	0.000148	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.49e-05	0.000147	CcSEcCtD
Naratriptan—Rash—Valproic Acid—epilepsy syndrome	6.44e-05	0.000146	CcSEcCtD
Naratriptan—Dermatitis—Valproic Acid—epilepsy syndrome	6.43e-05	0.000146	CcSEcCtD
Naratriptan—Headache—Valproic Acid—epilepsy syndrome	6.4e-05	0.000145	CcSEcCtD
Naratriptan—Paraesthesia—Topiramate—epilepsy syndrome	6.39e-05	0.000145	CcSEcCtD
Naratriptan—Dyspnoea—Topiramate—epilepsy syndrome	6.35e-05	0.000144	CcSEcCtD
Naratriptan—Somnolence—Topiramate—epilepsy syndrome	6.33e-05	0.000144	CcSEcCtD
Naratriptan—Diarrhoea—Pregabalin—epilepsy syndrome	6.31e-05	0.000144	CcSEcCtD
Naratriptan—Hypersensitivity—Gabapentin—epilepsy syndrome	6.24e-05	0.000142	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.15e-05	0.00014	CcSEcCtD
Naratriptan—Fatigue—Topiramate—epilepsy syndrome	6.14e-05	0.00014	CcSEcCtD
Naratriptan—Dizziness—Pregabalin—epilepsy syndrome	6.1e-05	0.000139	CcSEcCtD
Naratriptan—Pain—Topiramate—epilepsy syndrome	6.09e-05	0.000138	CcSEcCtD
Naratriptan—Constipation—Topiramate—epilepsy syndrome	6.09e-05	0.000138	CcSEcCtD
Naratriptan—Asthenia—Gabapentin—epilepsy syndrome	6.07e-05	0.000138	CcSEcCtD
Naratriptan—Nausea—Valproic Acid—epilepsy syndrome	6.06e-05	0.000138	CcSEcCtD
Naratriptan—Pruritus—Gabapentin—epilepsy syndrome	5.99e-05	0.000136	CcSEcCtD
Naratriptan—Vomiting—Pregabalin—epilepsy syndrome	5.87e-05	0.000133	CcSEcCtD
Naratriptan—Feeling abnormal—Topiramate—epilepsy syndrome	5.87e-05	0.000133	CcSEcCtD
Naratriptan—Rash—Pregabalin—epilepsy syndrome	5.82e-05	0.000132	CcSEcCtD
Naratriptan—Dermatitis—Pregabalin—epilepsy syndrome	5.81e-05	0.000132	CcSEcCtD
Naratriptan—Diarrhoea—Gabapentin—epilepsy syndrome	5.79e-05	0.000132	CcSEcCtD
Naratriptan—Headache—Pregabalin—epilepsy syndrome	5.78e-05	0.000131	CcSEcCtD
Naratriptan—Urticaria—Topiramate—epilepsy syndrome	5.66e-05	0.000129	CcSEcCtD
Naratriptan—Body temperature increased—Topiramate—epilepsy syndrome	5.63e-05	0.000128	CcSEcCtD
Naratriptan—Dizziness—Gabapentin—epilepsy syndrome	5.6e-05	0.000127	CcSEcCtD
Naratriptan—Nausea—Pregabalin—epilepsy syndrome	5.48e-05	0.000125	CcSEcCtD
Naratriptan—Vomiting—Gabapentin—epilepsy syndrome	5.38e-05	0.000122	CcSEcCtD
Naratriptan—Rash—Gabapentin—epilepsy syndrome	5.34e-05	0.000121	CcSEcCtD
Naratriptan—Dermatitis—Gabapentin—epilepsy syndrome	5.33e-05	0.000121	CcSEcCtD
Naratriptan—Headache—Gabapentin—epilepsy syndrome	5.3e-05	0.00012	CcSEcCtD
Naratriptan—Hypersensitivity—Topiramate—epilepsy syndrome	5.25e-05	0.000119	CcSEcCtD
Naratriptan—Asthenia—Topiramate—epilepsy syndrome	5.11e-05	0.000116	CcSEcCtD
Naratriptan—Pruritus—Topiramate—epilepsy syndrome	5.04e-05	0.000114	CcSEcCtD
Naratriptan—Nausea—Gabapentin—epilepsy syndrome	5.03e-05	0.000114	CcSEcCtD
Naratriptan—Diarrhoea—Topiramate—epilepsy syndrome	4.87e-05	0.000111	CcSEcCtD
Naratriptan—Dizziness—Topiramate—epilepsy syndrome	4.71e-05	0.000107	CcSEcCtD
Naratriptan—Vomiting—Topiramate—epilepsy syndrome	4.53e-05	0.000103	CcSEcCtD
Naratriptan—Rash—Topiramate—epilepsy syndrome	4.49e-05	0.000102	CcSEcCtD
Naratriptan—Dermatitis—Topiramate—epilepsy syndrome	4.49e-05	0.000102	CcSEcCtD
Naratriptan—Headache—Topiramate—epilepsy syndrome	4.46e-05	0.000101	CcSEcCtD
Naratriptan—Nausea—Topiramate—epilepsy syndrome	4.23e-05	9.61e-05	CcSEcCtD
Naratriptan—HTR1D—Signaling Pathways—OXT—epilepsy syndrome	2.35e-05	0.000108	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HSPB1—epilepsy syndrome	2.35e-05	0.000108	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HBEGF—epilepsy syndrome	2.34e-05	0.000108	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AGT—epilepsy syndrome	2.32e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCR5—epilepsy syndrome	2.32e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FYN—epilepsy syndrome	2.31e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CDC42—epilepsy syndrome	2.31e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GAL—epilepsy syndrome	2.31e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GFAP—epilepsy syndrome	2.31e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—H2AFX—epilepsy syndrome	2.31e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MEF2C—epilepsy syndrome	2.3e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT3—epilepsy syndrome	2.3e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HSPB1—epilepsy syndrome	2.3e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL3—epilepsy syndrome	2.3e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL2—epilepsy syndrome	2.3e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CRH—epilepsy syndrome	2.3e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OXT—epilepsy syndrome	2.3e-05	0.000106	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP2D6—epilepsy syndrome	2.29e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP2—epilepsy syndrome	2.28e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CHRM3—epilepsy syndrome	2.28e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GRM5—epilepsy syndrome	2.28e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCR5—epilepsy syndrome	2.27e-05	0.000104	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—epilepsy syndrome	2.27e-05	0.000104	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AVP—epilepsy syndrome	2.24e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—YWHAZ—epilepsy syndrome	2.22e-05	0.000102	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—epilepsy syndrome	2.22e-05	0.000102	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NGF—epilepsy syndrome	2.2e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CX3CR1—epilepsy syndrome	2.19e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.19e-05	0.0001	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTK2B—epilepsy syndrome	2.18e-05	0.0001	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TSC1—epilepsy syndrome	2.18e-05	0.0001	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADRA2A—epilepsy syndrome	2.18e-05	0.0001	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—BCHE—epilepsy syndrome	2.17e-05	9.97e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AGT—epilepsy syndrome	2.15e-05	9.87e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CHRM2—epilepsy syndrome	2.15e-05	9.86e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BDKRB1—epilepsy syndrome	2.15e-05	9.86e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CX3CL1—epilepsy syndrome	2.15e-05	9.86e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.14e-05	9.83e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCR5—epilepsy syndrome	2.14e-05	9.82e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TSC1—epilepsy syndrome	2.14e-05	9.81e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTK2B—epilepsy syndrome	2.14e-05	9.81e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR2—epilepsy syndrome	2.12e-05	9.74e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SST—epilepsy syndrome	2.12e-05	9.74e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NTRK2—epilepsy syndrome	2.12e-05	9.74e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AGT—epilepsy syndrome	2.11e-05	9.66e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—DUSP6—epilepsy syndrome	2.1e-05	9.66e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CDC42—epilepsy syndrome	2.1e-05	9.63e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—epilepsy syndrome	2.09e-05	9.61e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GABBR1—epilepsy syndrome	2.09e-05	9.59e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NTRK2—epilepsy syndrome	2.08e-05	9.54e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR2—epilepsy syndrome	2.08e-05	9.54e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SST—epilepsy syndrome	2.08e-05	9.54e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADRA2A—epilepsy syndrome	2.08e-05	9.54e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—SLC2A1—epilepsy syndrome	2.07e-05	9.51e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PLAT—epilepsy syndrome	2.07e-05	9.5e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—DUSP6—epilepsy syndrome	2.06e-05	9.46e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PLCB1—epilepsy syndrome	2.05e-05	9.4e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TH—epilepsy syndrome	2.04e-05	9.37e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADRA2A—epilepsy syndrome	2.03e-05	9.34e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AVP—epilepsy syndrome	2.03e-05	9.32e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PLAT—epilepsy syndrome	2.03e-05	9.3e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HRH3—epilepsy syndrome	2e-05	9.19e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL12—epilepsy syndrome	2e-05	9.16e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BDKRB2—epilepsy syndrome	2e-05	9.16e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—POMC—epilepsy syndrome	1.99e-05	9.15e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TSC2—epilepsy syndrome	1.99e-05	9.13e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PRKCB—epilepsy syndrome	1.99e-05	9.12e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AGT—epilepsy syndrome	1.99e-05	9.12e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6ST—epilepsy syndrome	1.98e-05	9.08e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OPRM1—epilepsy syndrome	1.97e-05	9.05e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—JUNB—epilepsy syndrome	1.96e-05	8.99e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CNR1—epilepsy syndrome	1.96e-05	8.99e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL12—epilepsy syndrome	1.95e-05	8.97e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.95e-05	8.97e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PLCB1—epilepsy syndrome	1.95e-05	8.96e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—POMC—epilepsy syndrome	1.95e-05	8.96e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—epilepsy syndrome	1.95e-05	8.93e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.95e-05	8.93e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.94e-05	8.89e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—JUNB—epilepsy syndrome	1.92e-05	8.81e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CNR1—epilepsy syndrome	1.92e-05	8.81e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PLCB1—epilepsy syndrome	1.91e-05	8.77e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR7—epilepsy syndrome	1.91e-05	8.77e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—KDR—epilepsy syndrome	1.91e-05	8.75e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.9e-05	8.73e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR7—epilepsy syndrome	1.87e-05	8.59e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR3—epilepsy syndrome	1.86e-05	8.55e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.86e-05	8.54e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HBEGF—epilepsy syndrome	1.86e-05	8.52e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PRKCB—epilepsy syndrome	1.84e-05	8.42e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6ST—epilepsy syndrome	1.83e-05	8.39e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT3—epilepsy syndrome	1.82e-05	8.36e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HBEGF—epilepsy syndrome	1.82e-05	8.34e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NPY—epilepsy syndrome	1.81e-05	8.33e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.81e-05	8.33e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—POMC—epilepsy syndrome	1.81e-05	8.31e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT3—epilepsy syndrome	1.78e-05	8.19e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADAM10—epilepsy syndrome	1.78e-05	8.17e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—POMC—epilepsy syndrome	1.77e-05	8.13e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL2—epilepsy syndrome	1.77e-05	8.13e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AGT—epilepsy syndrome	1.77e-05	8.11e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	1.75e-05	8.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	1.75e-05	8.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	1.75e-05	8.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	1.75e-05	8.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	1.75e-05	8.04e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADAM10—epilepsy syndrome	1.74e-05	8e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL2—epilepsy syndrome	1.73e-05	7.96e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	1.73e-05	7.93e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HMOX1—epilepsy syndrome	1.7e-05	7.82e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.69e-05	7.76e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—S100B—epilepsy syndrome	1.68e-05	7.72e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAT—epilepsy syndrome	1.68e-05	7.72e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—POMC—epilepsy syndrome	1.67e-05	7.67e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SOCS3—epilepsy syndrome	1.67e-05	7.65e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDC42—epilepsy syndrome	1.66e-05	7.63e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—S100B—epilepsy syndrome	1.65e-05	7.56e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL2—epilepsy syndrome	1.64e-05	7.51e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ABCB1—epilepsy syndrome	1.64e-05	7.51e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.63e-05	7.49e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SOCS3—epilepsy syndrome	1.63e-05	7.49e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	1.63e-05	7.47e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	1.63e-05	7.47e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDC42—epilepsy syndrome	1.63e-05	7.47e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AVP—epilepsy syndrome	1.61e-05	7.38e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	1.6e-05	7.36e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	1.58e-05	7.27e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	1.58e-05	7.27e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SST—epilepsy syndrome	1.58e-05	7.27e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AVP—epilepsy syndrome	1.58e-05	7.23e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	1.57e-05	7.2e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.55e-05	7.11e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	1.54e-05	7.08e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HES1—epilepsy syndrome	1.52e-05	6.98e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GPX1—epilepsy syndrome	1.52e-05	6.98e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HES1—epilepsy syndrome	1.49e-05	6.84e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.49e-05	6.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	1.49e-05	6.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	1.49e-05	6.82e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.48e-05	6.8e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FYN—epilepsy syndrome	1.48e-05	6.79e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FGF2—epilepsy syndrome	1.48e-05	6.79e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.48e-05	6.78e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—H2AFX—epilepsy syndrome	1.47e-05	6.77e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MEF2C—epilepsy syndrome	1.47e-05	6.75e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	1.46e-05	6.71e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	1.46e-05	6.71e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	1.46e-05	6.68e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FYN—epilepsy syndrome	1.45e-05	6.65e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.44e-05	6.63e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.44e-05	6.61e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	1.43e-05	6.54e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—YWHAZ—epilepsy syndrome	1.42e-05	6.53e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NGF—epilepsy syndrome	1.41e-05	6.45e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.39e-05	6.39e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	1.38e-05	6.35e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	1.38e-05	6.32e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RELA—epilepsy syndrome	1.37e-05	6.3e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR5—epilepsy syndrome	1.37e-05	6.28e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	1.36e-05	6.24e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	1.35e-05	6.2e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MTOR—epilepsy syndrome	1.35e-05	6.18e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	1.34e-05	6.15e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—epilepsy syndrome	1.34e-05	6.14e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AGT—epilepsy syndrome	1.33e-05	6.12e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	1.33e-05	6.09e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	1.32e-05	6.06e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.31e-05	6.02e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—epilepsy syndrome	1.31e-05	5.99e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TSC2—epilepsy syndrome	1.27e-05	5.84e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AGT—epilepsy syndrome	1.27e-05	5.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	1.25e-05	5.76e-05	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—epilepsy syndrome	1.25e-05	5.73e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	1.25e-05	5.72e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—epilepsy syndrome	1.24e-05	5.71e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	1.24e-05	5.71e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.24e-05	5.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	1.24e-05	5.69e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—epilepsy syndrome	1.24e-05	5.68e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KDR—epilepsy syndrome	1.22e-05	5.6e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	1.22e-05	5.59e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—JUN—epilepsy syndrome	1.2e-05	5.52e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	1.2e-05	5.51e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	1.19e-05	5.48e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCB—epilepsy syndrome	1.17e-05	5.39e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—epilepsy syndrome	1.17e-05	5.37e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6ST—epilepsy syndrome	1.17e-05	5.37e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.15e-05	5.28e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.14e-05	5.25e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	1.13e-05	5.21e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—epilepsy syndrome	1.13e-05	5.21e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—epilepsy syndrome	1.12e-05	5.15e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	1.1e-05	5.07e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.1e-05	5.05e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.1e-05	5.04e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SRC—epilepsy syndrome	1.08e-05	4.95e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	1.07e-05	4.91e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.06e-05	4.87e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—epilepsy syndrome	1.05e-05	4.82e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.05e-05	4.81e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	1.05e-05	4.81e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	1.05e-05	4.8e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	1.02e-05	4.7e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—epilepsy syndrome	1.02e-05	4.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.02e-05	4.68e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	9.99e-06	4.58e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	9.49e-06	4.35e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	9.48e-06	4.35e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	9.45e-06	4.34e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	9.28e-06	4.26e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	9.26e-06	4.25e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	9.1e-06	4.17e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—epilepsy syndrome	8.95e-06	4.11e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	8.78e-06	4.03e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	8.76e-06	4.02e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	8.72e-06	4e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	8.61e-06	3.95e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	8.59e-06	3.94e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	8.43e-06	3.87e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	7.99e-06	3.67e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	7.98e-06	3.66e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	7.92e-06	3.63e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.82e-06	3.59e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	7.8e-06	3.58e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	7.75e-06	3.56e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	7.69e-06	3.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	7.53e-06	3.46e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	7.48e-06	3.43e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	7.33e-06	3.36e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	7.26e-06	3.33e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	7.1e-06	3.26e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	7.05e-06	3.24e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	6.9e-06	3.17e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	6.75e-06	3.1e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	6.72e-06	3.08e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	6.7e-06	3.08e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	6.58e-06	3.02e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	6.55e-06	3e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	6.42e-06	2.95e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.96e-06	2.74e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	5.91e-06	2.71e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	5.74e-06	2.63e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	5.58e-06	2.56e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	5.41e-06	2.48e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	5.14e-06	2.36e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	5.01e-06	2.3e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—epilepsy syndrome	4.5e-06	2.06e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	4.29e-06	1.97e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	4.2e-06	1.93e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	3.2e-06	1.47e-05	CbGpPWpGaD
